FDA Investigator Andria L Kuhlman

Andria L Kuhlman has conducted inspections on 194 sites in 9 countries as of 19 Dec 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
194
Last Inspection Date:
19 Dec 2019
Investigator Role:
FDA Investigator
Redica ID:
100005960
Countries of Inspections:
United States of America, Czechia, Canada, Italy, Philippines, Belgium, United Kingdom of Great Britain and Northern Ireland, Botswana, Hungary
FDA Investigators that have inspected at least one site in common with Andria L Kuhlman:
Alan Escalona, Alexandra B Pitkin, Allison C Hunter, Allison E Sincek, Allison M Scheck, Amy A Johnson, Amy C Amaro, Andrew I Carr, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anna M Brannen, Arie R Dyk, Ashley R Karns, Azza Talaat, Benjamin P Stewart, Bryan J Love, Carlos H Ruiz, Cassandra L Winters, Catherine D Djordjevic, Charles C Conn, III, Ching Jeyg Chang, Christian D Lynch (CDL), Christian L Witkovskie, Christopher T Middendorf, Connie R Kiessling, Craig P Seaborn, Craig T Rybus, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Cynthia L Rakestraw, D'arbra R Blankenship, Darla J Christopher, Darren S Morgan, Dawn C Olenjack, Dell S Moller, Diane Hall, Diane R Mcdaniel, Dorathy M Eischen, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edwin Melendez, Elizabeth Ll Edwards, Elizabeth P Kinsella, Emest F Bizjak, Evan M Kupper, Felipe Rde Almeida, Frederick M Lochner, Geoffrey K Kilili, Gerald Mierle, Gilbert J Heidenblut, Guy W Cartwright, Helen B Ricalde, Holly J Wilson, Hugh M Mcclure, II, James G Marsh, Janet L Bowen, Janete F Guardia, Javonica F Penn, Jazmine N Still, Jeffrey A Sincek, Jennifer L Jager, Jennifer L Sheehan, Jennifer M Heitz, Jocelyn E Massey, Jonee J Mearns, Jose Acruz Gonzalez, Juan C Gonzalez Rivera, Judy Ellen Ciaraldi, Julie D Bringger, Karen M Cooper, Karen M Kondas, Kathleen D Culver, Kathryn J Mccarty, Keith J Mason, Jr, Kelli L Wilkinson, Kenneth E Felkley, Kenneth L Smalls, Kimberly A Joseph, Kirk A Dymbrowski, Laine P Myers, Laressa R Gray, Laura E Garcia, Laura L Staples, LCDR Wilfred A Darang, Leena Thomas, Leslie R Clark, Libia M Lugo, Linda R Kuchenthal, Lindsey M Schwierjohann, Lisa Hayka, Lori A Gioia, Luann Mckinney, Malik S Qaiser, Marcelo O Mangalindan, Jr, Marcia A Worley, Margarita Santiago, Marianne Allen, Maribeth G Niesen, Mark E Parmon, Mary E Storch, Matt D Suedkamp, Matthew B Casale, Matthew H Pitts, Matthew J Gretkierewicz, Michael D Thatcher, Michael E Campbell, Michael E Clark, Michael Freeman, REHS, Michael J Schibi, Michael K Larson, Miguel A Martinez Perez, Nadeem I Chaudhry, Nancy L Neiger, Nicholas L Paulin, Nisha C Patel, Norman Wong, Nutan Mytle, Patricia A Mcilroy, Paul L Figarole, Jr, Phillip M Pontikos, Pifer, Rafael E Arroyo, Rebecca Rodriguez, Richard J Bashay, Richard W Berning, Robert Rodriguez, Rosanna M Goodrich, Rose Ashley, Sherry L Secrist, BLT DO, Sidney B Priesmeyer, Stephen D Brown, Stephen J Kilker, Stephen J Rabe, Steven A Gonzales, Susan M Taylor, Tamara M Kays, Ted L Anderson, Theresa C Klaman, Thomas J Prigge, Thomas W Nojek, Thunder N Dunkijacobs, Tracey L Harris, Travis R Hunt, Ucheabuchi Cchudi Nwankwor, Vanessa E Coulter, Xiaokuang Lai, PhD, Yvette Mlacour Davis, Zachary L Miller

Andria L Kuhlman's Documents

Publish Date Document Type Title
March, 2010 EIR James N. Allen, M.d. - EIR, 2010-03-01
April, 2015 FDA 483 Namita Sood - Form 483, 2015-04-08
May, 2014 FDA 483 Michael Aman PhD - Form 483, 2014-05-09
October, 2014 EIR Battelle Memorial Institute - EIR, 2014-10-10
March, 2016 EIR David J. Portman M.D. - EIR, 2016-03-17
May, 2014 EIR Douglas R Schumacher MD - EIR, 2014-05-28
December, 2013 EIR Columbus CCOP IRB - EIR, 2013-12-18
October, 2012 EIR Shelly L Dunmyer MD - EIR, 2012-10-05
October, 2016 EIR Douglas R Schumacher MD - EIR, 2016-10-03
August, 2012 FDA 483 Response Csl Plasma - Form 483R, 2012-09-13
August, 2016 FDA 483 Response Jerry R Mendell MD - Form 483R, 2016-09-08
August, 2012 EIR Csl Plasma - EIR, 2012-08-30
December, 2011 FDA 483 Battelle Memorial Institute - Form 483, 2011-12-22
April, 2014 FDA 483 Battelle Memorial Institute - Form 483, 2014-04-04
November, 2014 EIR Vivek R Awasty MD - EIR, 2014-11-20
October, 2014 FDA 483 Battelle Memorial Institute - Form 483, 2014-10-10
October, 2012 EIR Battelle Memorial Institute - EIR, 2012-10-17
February, 2015 FDA 483 Shelly L Dunmyer MD - Form 483, 2015-02-03
October, 2012 FDA 483 Response Battelle Memorial Institute - Form 483R, 2012-10-24
May, 2014 EIR Michael Aman PhD - EIR, 2014-05-09
August, 2016 EIR Jerry R Mendell MD - EIR, 2016-08-19
April, 2015 EIR Namita Sood - EIR, 2015-04-08
November, 2014 FDA 483 Vivek R Awasty MD - Form 483, 2014-11-05
November, 2014 EIR Vivek R Awasty MD - EIR, 2014-11-05
October, 2012 FDA 483 Battelle Memorial Institute - Form 483, 2012-10-17
November, 2014 FDA 483 Vivek R Awasty MD - Form 483, 2014-11-20
March, 2010 FDA 483 James N. Allen, M.d. - Form 483, 2010-03-01
August, 2012 FDA 483 Csl Plasma - Form 483, 2012-08-30
February, 2015 EIR Shelly L Dunmyer MD - EIR, 2015-02-03
April, 2014 EIR Battelle Memorial Institute - EIR, 2014-04-04
August, 2016 FDA 483 Jerry R Mendell MD - Form 483, 2016-08-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more